Overview

DuoTrav APS Versus XALACOM® in Ocular Surface Health

Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
To demonstrate superiority of DuoTrav APS over XALACOM® in Ocular Surface Health in patients with open angle glaucoma or ocular hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research